Cecilia Hillard - Publications

Affiliations: 
Pharmacology and Toxicology Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Neuropharmacology

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Roberts CJ, Hillard CJ. Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic-pituitary-adrenal axis activation via a non-CB1R mechanism. Endocrine. PMID 33216305 DOI: 10.1007/s12020-020-02549-1  0.32
2020 Carter GT, McLaughlin RJ, Cuttler C, Sauber GJ, Weeks DL, Hillard CJ, Weiss MD. Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. Muscle & Nerve. PMID 33094490 DOI: 10.1002/mus.27096  0.501
2020 Doncheck EM, Liddiard GT, Konrath CD, Liu X, Yu L, Urbanik LA, Herbst MR, DeBaker MC, Raddatz N, Van Newenhizen EC, Mathy J, Gilmartin MR, Liu QS, Hillard CJ, Mantsch JR. Sex, stress, and prefrontal cortex: influence of biological sex on stress-promoted cocaine seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32303052 DOI: 10.1038/S41386-020-0674-3  0.762
2020 Hanlon EC, Leproult R, Stuhr KL, Doncheck EM, Hillard CJ, Van Cauter E. Circadian misalignment of the 24-hr profile of endocannabinoid 2-arachidonoylglycerol (2-AG) in obese adults. The Journal of Clinical Endocrinology and Metabolism. PMID 31970413 DOI: 10.1210/Clinem/Dgaa028  0.727
2019 Yasmin F, Colangeli R, Morena M, Filipski S, van der Stelt M, Pittman QJ, Hillard CJ, Teskey GC, McEwen BS, Hill MN, Chattarji S. Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala. Proceedings of the National Academy of Sciences of the United States of America. PMID 31843894 DOI: 10.1073/Pnas.1910322116  0.737
2019 Moe A, Sauber G, Zhou V, Lapitz A, Hillard C, Drobyski WR. Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease Blood. 134: 195-195. DOI: 10.1182/Blood-2019-122746  0.341
2018 Hill MN, Eiland L, Lee TTY, Hillard CJ, McEwen BS. Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats. Neuropharmacology. PMID 30496752 DOI: 10.1016/J.Neuropharm.2018.11.036  0.618
2018 Balsevich G, Sticht M, Bowles NP, Singh A, Lee TTY, Li Z, Chelikani PK, Lee FS, Borgland SL, Hillard CJ, McEwen BS, Hill MN. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance. Proceedings of the National Academy of Sciences of the United States of America. PMID 29967158 DOI: 10.1073/Pnas.1802251115  0.572
2018 Berger AL, Henricks AM, Lugo JM, Wright HR, Warrick CR, Sticht MA, Morena M, Bonilla I, Laredo SA, Craft RM, Parsons LH, Grandes PR, Hillard CJ, Hill MN, McLaughlin RJ. The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System. Biological Psychiatry. PMID 29887035 DOI: 10.1016/J.Biopsych.2018.04.018  0.769
2017 McReynolds JR, Doncheck EM, Li Y, Vranjkovic O, Graf EN, Ogasawara D, Cravatt BF, Baker DA, Liu QS, Hillard CJ, Mantsch JR. Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid Mobilization in the Prelimbic Cortex. Biological Psychiatry. PMID 29100630 DOI: 10.1016/J.Biopsych.2017.09.024  0.775
2017 Doncheck EM, Urbanik LA, DeBaker MC, Barron LM, Liddiard GT, Tuscher JJ, Frick KM, Hillard CJ, Mantsch JR. 17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28825421 DOI: 10.1038/Npp.2017.170  0.757
2016 Hillard CJ, Beatka M, Sarvaideo J. Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis. Comprehensive Physiology. 7: 1-15. PMID 28134998 DOI: 10.1002/cphy.c160005  0.301
2016 Gray JM, Wilson CD, Lee TT, Pittman QJ, Deussing JM, Hillard CJ, McEwen BS, Schulkin J, Karatsoreos IN, Patel S, Hill MN. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Psychoneuroendocrinology. 66: 151-158. PMID 26821211 DOI: 10.1016/J.Psyneuen.2016.01.004  0.774
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol. Sleep. PMID 26612385 DOI: 10.5665/Sleep.5546  0.729
2015 McReynolds JR, Doncheck EM, Vranjkovic O, Ganzman GS, Baker DA, Hillard CJ, Mantsch JR. CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats. Psychopharmacology. PMID 26455361 DOI: 10.1007/S00213-015-4092-X  0.78
2015 Lee TT, Hill MN, Hillard CJ, Gorzalka BB. Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats. Neuropharmacology. 99: 89-97. PMID 26192544 DOI: 10.1016/J.Neuropharm.2015.07.021  0.749
2015 Bowles NP, Karatsoreos IN, Li X, Vemuri VK, Wood JA, Li Z, Tamashiro KL, Schwartz GJ, Makriyannis AM, Kunos G, Hillard CJ, McEwen BS, Hill MN. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America. 112: 285-90. PMID 25535367 DOI: 10.1073/Pnas.1421420112  0.602
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. The Journal of Clinical Endocrinology and Metabolism. 100: 220-6. PMID 25368979 DOI: 10.1210/Jc.2014-3455  0.737
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, De Wit H, Hillard CJ, Van Cauter E. Circadian rhythm of circulating levels of the endocannabinoid 2 arachidonoylglycerol Journal of Clinical Endocrinology and Metabolism. 100: 220-226. DOI: 10.1210/jc.20143455  0.725
2014 Hillard CJ. Stress regulates endocannabinoid-CB1 receptor signaling. Seminars in Immunology. 26: 380-8. PMID 24882055 DOI: 10.1016/j.smim.2014.04.001  0.373
2014 Hillard CJ, Liu Qs, Liu X, Pan B, Roberts CJ, Shi L. Cannabinoids, endocannabinoids and stress Cannabinoids. 139-174. DOI: 10.1002/9781118451281.ch5  0.474
2013 Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology. 38: 2952-61. PMID 24035186 DOI: 10.1016/J.Psyneuen.2013.08.004  0.59
2013 McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB. Upregulation of CB₁ receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behavioural Brain Research. 237: 333-7. PMID 23047058 DOI: 10.1016/J.Bbr.2012.09.053  0.813
2013 Lee TT, Hill MN, Hillard CJ, Gorzalka BB. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse (New York, N.Y.). 67: 4-10. PMID 22987804 DOI: 10.1002/Syn.21609  0.729
2013 Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Molecular Psychiatry. 18: 1125-35. PMID 22776900 DOI: 10.1038/Mp.2012.90  0.632
2012 Klein C, Hill MN, Chang SC, Hillard CJ, Gorzalka BB. Circulating endocannabinoid concentrations and sexual arousal in women. The Journal of Sexual Medicine. 9: 1588-601. PMID 22462722 DOI: 10.1111/J.1743-6109.2012.02708.X  0.693
2012 Ho WS, Hill MN, Miller GE, Gorzalka BB, Hillard CJ. Serum contents of endocannabinoids are correlated with blood pressure in depressed women. Lipids in Health and Disease. 11: 32. PMID 22373123 DOI: 10.1186/1476-511X-11-32  0.699
2012 McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 664-71. PMID 22325231 DOI: 10.1016/J.Euroneuro.2012.01.004  0.813
2012 Bowles NP, Hill MN, Bhagat SM, Karatsoreos IN, Hillard CJ, McEwen BS. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience. 204: 83-9. PMID 21939741 DOI: 10.1016/J.Neuroscience.2011.08.048  0.673
2012 Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. Journal of Psychopharmacology (Oxford, England). 26: 56-70. PMID 21890595 DOI: 10.1177/0269881111409606  0.768
2011 Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB, Hillard CJ. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 10506-15. PMID 21775596 DOI: 10.1523/Jneurosci.0496-11.2011  0.831
2011 Hill MN, Hillard CJ, McEwen BS. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. Cerebral Cortex (New York, N.Y. : 1991). 21: 2056-64. PMID 21263035 DOI: 10.1093/Cercor/Bhq280  0.645
2011 Hill JE, Makky K, Shrestha L, Hillard CJ, Gasser PJ. Natural and synthetic corticosteroids inhibit uptake 2-mediated transport in CNS neurons. Physiology & Behavior. 104: 306-11. PMID 21081135 DOI: 10.1016/J.Physbeh.2010.11.012  0.77
2010 Krebs-Kraft DL, Hill MN, Hillard CJ, McCarthy MM. Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior. Proceedings of the National Academy of Sciences of the United States of America. 107: 20535-40. PMID 21059913 DOI: 10.1073/Pnas.1005003107  0.504
2010 Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology. 151: 4811-9. PMID 20702575 DOI: 10.1210/En.2010-0285  0.557
2010 Ho WS, Patel S, Thompson JR, Roberts CJ, Stuhr KL, Hillard CJ. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. British Journal of Pharmacology. 160: 736-46. PMID 20590576 DOI: 10.1111/J.1476-5381.2010.00772.X  0.622
2010 Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? British Journal of Pharmacology. 160: 530-43. PMID 20590563 DOI: 10.1111/J.1476-5381.2010.00790.X  0.483
2010 Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, Gorzalka BB, Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences of the United States of America. 107: 9406-11. PMID 20439721 DOI: 10.1073/Pnas.0914661107  0.778
2010 Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 35: 1333-8. PMID 20399021 DOI: 10.1016/J.Psyneuen.2010.03.005  0.61
2010 Riebe CJ, Hill MN, Lee TT, Hillard CJ, Gorzalka BB. Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrinology. 35: 1265-9. PMID 20207489 DOI: 10.1016/J.Psyneuen.2010.02.008  0.752
2010 Hill MN, Titterness AK, Morrish AC, Carrier EJ, Lee TT, Gil-Mohapel J, Gorzalka BB, Hillard CJ, Christie BR. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus. 20: 513-23. PMID 19489006 DOI: 10.1002/Hipo.20647  0.793
2009 Patel S, Hillard CJ. Role of endocannabinoid signaling in anxiety and depression. Current Topics in Behavioral Neurosciences. 1: 347-71. PMID 21104391 DOI: 10.1007/978-3-540-88955-7_14  0.562
2009 Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences. 30: 484-93. PMID 19732971 DOI: 10.1016/J.Tips.2009.06.006  0.785
2009 Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2733-45. PMID 19710634 DOI: 10.1038/Npp.2009.114  0.831
2009 Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology. 34: 1257-62. PMID 19394765 DOI: 10.1016/J.Psyneuen.2009.03.013  0.796
2009 Hill MN, Ho WSV, Hillard CJ, Gorzalka BB. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents (Journal of Neural Transmission (2008) 115, (1673-1679) DOI: 10.1007/s00702-008-0131-7) Journal of Neural Transmission. 116: 141. DOI: 10.1007/s00702-008-0172-y  0.739
2008 Hill MN, Ho WS, Hillard CJ, Gorzalka BB. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1673-9. PMID 18974922 DOI: 10.1007/S00702-008-0131-7  0.761
2008 Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, Gorzalka BB. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. Journal of Neurochemistry. 106: 2322-36. PMID 18643796 DOI: 10.1111/J.1471-4159.2008.05567.X  0.797
2008 Patel S, Hillard CJ. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. The European Journal of Neuroscience. 27: 2821-9. PMID 18588527 DOI: 10.1111/J.1460-9568.2008.06266.X  0.578
2008 Gorzalka BB, Hill MN, Hillard CJ. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neuroscience and Biobehavioral Reviews. 32: 1152-60. PMID 18433869 DOI: 10.1016/J.Neubiorev.2008.03.004  0.756
2008 Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 41: 48-53. PMID 18311684 DOI: 10.1055/S-2007-993211  0.701
2008 Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus. 18: 221-6. PMID 18058925 DOI: 10.1002/Hipo.20386  0.812
2008 Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology. 54: 108-16. PMID 17675104 DOI: 10.1016/J.Neuropharm.2007.06.012  0.786
2007 Hillard CJ, Shi L, Tuniki VR, Falck JR, Campbell WB. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. Journal of Molecular Neuroscience : Mn. 33: 18-24. PMID 17901541 DOI: 10.1007/S12031-007-0045-0  0.409
2007 Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. Journal of Neurochemistry. 103: 47-56. PMID 17561935 DOI: 10.1111/J.1471-4159.2007.04688.X  0.808
2007 Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nature Medicine. 13: 492-7. PMID 17401376 DOI: 10.1038/Nm1561  0.699
2007 Rademacher DJ, Hillard CJ. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 633-41. PMID 17258369 DOI: 10.1016/j.pnpbp.2006.12.013  0.343
2006 Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2591-9. PMID 16710317 DOI: 10.1038/Sj.Npp.1301092  0.777
2006 Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences of the United States of America. 103: 7895-900. PMID 16672367 DOI: 10.1073/Pnas.0511232103  0.72
2006 Patel S, Hillard CJ. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. The Journal of Pharmacology and Experimental Therapeutics. 318: 304-11. PMID 16569753 DOI: 10.1124/Jpet.106.101287  0.569
2005 Carrier EJ, Patel S, Hillard CJ. Endocannabinoids in neuroimmunology and stress. Current Drug Targets. Cns and Neurological Disorders. 4: 657-65. PMID 16375683 DOI: 10.2174/156800705774933023  0.794
2005 Hill MN, Ho WS, Meier SE, Gorzalka BB, Hillard CJ. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. European Journal of Pharmacology. 528: 99-102. PMID 16324692 DOI: 10.1016/J.Ejphar.2005.10.058  0.759
2005 Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. Journal of Neurochemistry. 95: 437-45. PMID 16086683 DOI: 10.1111/J.1471-4159.2005.03380.X  0.722
2005 Hillard CJ, Jarrahian A. Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology. 48: 1072-8. PMID 15910883 DOI: 10.1016/J.Neuropharm.2004.12.012  0.728
2005 Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. The European Journal of Neuroscience. 21: 1057-69. PMID 15787710 DOI: 10.1111/J.1460-9568.2005.03916.X  0.612
2005 Rademacher DJ, Patel S, Ho WS, Savoie AM, Rusch NJ, Gauthier KM, Hillard CJ. U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance. American Journal of Physiology. Heart and Circulatory Physiology. 288: H2694-701. PMID 15695564 DOI: 10.1152/Ajpheart.00978.2004  0.572
2005 Patel S, Carrier EJ, Ho WS, Rademacher DJ, Cunningham S, Reddy DS, Falck JR, Cravatt BF, Hillard CJ. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. Journal of Lipid Research. 46: 342-9. PMID 15576840 DOI: 10.1194/Jlr.M400377-Jlr200  0.735
2005 Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 508-15. PMID 15525997 DOI: 10.1038/Sj.Npp.1300601  0.802
2005 Patel S, Cravatt BF, Hillard CJ. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 497-507. PMID 15280883 DOI: 10.1038/Sj.Npp.1300535  0.625
2004 Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience. 129: 743-50. PMID 15541895 DOI: 10.1016/J.Neuroscience.2004.08.044  0.792
2004 Lu H, Patel S, Luo F, Li SJ, Hillard CJ, Ward BD, Hyde JS. Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magnetic Resonance in Medicine. 52: 1060-8. PMID 15508149 DOI: 10.1002/Mrm.20265  0.499
2004 Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 145: 5431-8. PMID 15331569 DOI: 10.1210/En.2004-0638  0.618
2004 Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Molecular Pharmacology. 65: 999-1007. PMID 15044630 DOI: 10.1124/Mol.65.4.999  0.801
2004 Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgado MA, Barkmeier A, Klick DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line. Journal of Neuroimmunology. 149: 130-41. PMID 15020073 DOI: 10.1016/J.Jneuroim.2003.12.022  0.767
2004 Seagard JL, Dean C, Patel S, Rademacher DJ, Hopp FA, Schmeling WT, Hillard CJ. Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. American Journal of Physiology. Heart and Circulatory Physiology. 286: H992-1000. PMID 14615281 DOI: 10.1152/Ajpheart.00870.2003  0.545
2003 Benito C, Núñez E, Tolón RM, Carrier EJ, Rábano A, Hillard CJ, Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11136-41. PMID 14657172 DOI: 10.1523/Jneurosci.23-35-11136.2003  0.708
2003 Hillard CJ, Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. British Journal of Pharmacology. 140: 802-8. PMID 12970089 DOI: 10.1038/Sj.Bjp.0705468  0.727
2003 Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. British Journal of Pharmacology. 139: 1005-13. PMID 12839875 DOI: 10.1038/Sj.Bjp.0705334  0.768
2003 Patel S, Rademacher DJ, Hillard CJ. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. The Journal of Pharmacology and Experimental Therapeutics. 306: 880-8. PMID 12808005 DOI: 10.1124/Jpet.103.054270  0.557
2003 Patel S, Hillard CJ. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Research. 963: 15-25. PMID 12560108 DOI: 10.1016/S0006-8993(02)03797-6  0.564
2003 Rademacher DJ, Patel S, Hopp FA, Dean C, Hillard CJ, Seagard JL. Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. American Journal of Physiology. Heart and Circulatory Physiology. 284: H1570-6. PMID 12521935 DOI: 10.1152/Ajpheart.00772.2002  0.567
2002 Patel S, Gerrits R, Muthian S, Greene AS, Hillard CJ. The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Neuroscience Letters. 335: 95-8. PMID 12459507 DOI: 10.1016/S0304-3940(02)01170-9  0.792
2001 Bisogno T, MacCarrone M, De Petrocellis L, Jarrahian A, Finazzi-Agrò A, Hillard C, Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. European Journal of Biochemistry / Febs. 268: 1982-9. PMID 11277920 DOI: 10.1046/J.1432-1327.2001.02072.X  0.746
2000 Hillard CJ, Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chemistry and Physics of Lipids. 108: 123-34. PMID 11106786 DOI: 10.1016/S0009-3084(00)00191-2  0.727
2000 Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. Journal of Neurochemistry. 74: 2597-606. PMID 10820223 DOI: 10.1046/J.1471-4159.2000.0742597.X  0.73
2000 Muthian S, Nithipatikom K, Campbell WB, Hillard CJ. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. The Journal of Pharmacology and Experimental Therapeutics. 293: 289-95. PMID 10734181  0.788
1999 Hillard CJ, Muthian S, Kearn CS. Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. Febs Letters. 459: 277-81. PMID 10518035 DOI: 10.1016/S0014-5793(99)01253-3  0.795
1999 Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. Journal of Neurochemistry. 72: 2379-87. PMID 10349847 DOI: 10.1046/J.1471-4159.1999.0722379.X  0.793
1998 Tsou K, Nogueron MI, Muthian S, Sañudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neuroscience Letters. 254: 137-40. PMID 10214976 DOI: 10.1016/S0304-3940(98)00700-9  0.784
1998 Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Molecular Pharmacology. 54: 180-8. PMID 9658204 DOI: 10.1124/Mol.54.1.180  0.791
1998 Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ. Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. The Journal of Pharmacology and Experimental Therapeutics. 286: 184-90. PMID 9655859  0.781
1997 Jarrahian A, Hillard CJ. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 57: 551-4. PMID 9431821 DOI: 10.1016/S0952-3278(97)90559-7  0.713
1997 Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry. 69: 631-8. PMID 9231721 DOI: 10.1046/J.1471-4159.1997.69020631.X  0.733
Show low-probability matches.